All News

Sequels always go bigger - and the Band of Ballers continues to grow

While there is currently no definitive way to predict who will respond and who will not, researchers at Brighton and Sussex Medical School in the United Kingdom are working on a blood test that could identify about half of those who may not.

Every year since 1994, we celebrate breast cancer awareness during the month of October. It's a special time of education and celebration. Learn more in this article.

Move over, Avengers. There's a new superhero crew coming through.

Deferring treatment may actually be beneficial for some patients with mantle cell lymphoma (MCL), according to recent research.

In recent years, treatment has expanded for mutations that are well-understood in this space.

Microsatellite instability is a genetic condition that could be difficult to understand. We broke it down to explain how it works.

The researchers found that the trial that led to the guidelines – which recommend screening based on age and smoking history – did not include fair representation from all groups across the nation.

When John McCain died this week, I was reminded of another patient who died of this nasty disease.

Cancer is a nasty side dish, but don't let it spoil the main course: your life.

A recent survey of physicians revealed that 17 percent of doctors with personal experience with cancer were more likely than those without to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.

Positive results, clinical utility, curtailed curiosity – has the desire for good news slowed the path to a cure?

As a parent facing cancer, we just want to know that our children will emerge on the other side of our diagnosis and be alright.

The FDA has approved Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.

Broad-based genomic sequencing, while useful in identifying tumor mutations in patients with non-small cell lung cancer (NSCLC), may not improve survival outcomes when compared to routine genomic testing.

Senator and former presidential candidate John McCain died of glioblastoma on Aug. 25. He was 81 years old.

If opting for the flat and fabulous look, it's important to learn to make friends with your belly because you're going to see it more often.

The senator's family announced that he will no longer be undergoing treatment for glioblastoma.

In a recent study, researchers from the American Cancer Society found that patients who reported higher satisfaction with their physician’s communication also had better health outcomes at lower costs.

"One of the big challenges in lymphoma is that many immune cells are present right in the tumor, but somehow those immune cells are not actually killing the tumor cells," explained Stephen M. Ansell, M.D., Ph.D.

An article Honoring the Hero for Colorado's Light the Night Walk.

According to a recent study conducted at the University of Alabama at Birmingham Schools of Public Health and Medicine, disparities among patients who receive instructions for this follow-up care still exist.

CURE spoke with Matthew Mossanen, M.D., from the Division of Urology at Brigham and Women’s Hospital, about what Bacillus Calmette-Guérin (BCG) is and what patients should know about this treatment option.

A guy with breast cancer ponders some of cancer's puzzling peculiarities.